Ozempic's Big Test
Briefly

The apparent drop in obesity rates, down to 40.3% from 41.9%, hints that the obesity epidemic might no longer be growing, marking a hopeful turning point.
Drugs like Ozempic and Mounjaro are being credited with improving health outcomes and causing significant weight loss, suggesting new treatment avenues for chronic weight-related issues.
Read at The Atlantic
[
|
]